Evidence map›Paper›PMID 39820730›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Is routine hearing screening necessary in patients with inflammatory bowel disease - a prospective study.

Nayanika Reddy, Vijendra S Shenoy, Navya Parvathareddy, Ishaan Aggarwal

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nayanika ReddyDepartment of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
Vijendra S ShenoyDepartment of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India. vijendra.shenoy@manipal.edu.ORCID http://orcid.org/0000-0002-2048-6373
Navya ParvathareddyDepartment of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
Ishaan AggarwalDepartment of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare audiological profiling and association of hearing loss in different types of IBD and evaluate the degree of hearing impairment based on duration of illness and age parameters.

methods120 subjects evaluated at a tertiary centre were divided into 2 groups- Controls and Cases. Cases were sub grouped into Ulcerative colitis (UC) and Crohn's disease based on biopsy. Hearing evaluation was done using PTA and DPOAE. Results were compared between the groups with analysis including duration of illness and age at presentation.

resultsMild hearing loss at 8000 Hz was noted in both the subgroups, more so in UC. The median dB loss on PTA was more in the UC group at all the frequencies but was significant only at 1000, 2000, 4000 and 8000 Hz. 53(44.1%) of the 120 ears, showed mild hearing loss at 8000 Hz on PTA. The median SNR was lower in both subgroups at 8000 Hz. At 8000 Hz on DPOAE, 80 ears (66.6%) showed absent response which was much higher as compared to PTA findings at this frequency. At 8000 Hz, patients with > 5 years duration of illness and those with age > 30 years, showed higher absent DPOAE responses namely 25 ears (83.4%) out of 30 ears and 56 ears (80%) of 70, respectively.

conclusionUC cases are more susceptible to hearing loss compared to Crohn's disease especially at 8000 Hz. DPOAE supersedes PTA as a diagnostic tool for subclinical hearing loss.

Indexed as

Colitis, UlcerativeCrohn DiseaseHearing LossInflammatory Bowel DiseasesAdultAgedAudiometry, Pure-ToneCase-Control StudiesFemaleHearing TestsHumansMaleMass ScreeningMiddle AgedProspective StudiesYoung AdultCrohn’s diseaseDistortion product otoacoustic emissionsHearing lossInflammatory bowel diseasePure tone audiometrySNRUlcerative colitis

Identifiers

PMID39820730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.